• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Biosimilar drugs in europe   threat or opportunity to innovation -- toc, exec summary and sample pages
 

Biosimilar drugs in europe threat or opportunity to innovation -- toc, exec summary and sample pages

on

  • 3,124 views

Generic Pharma 2.0 has teamed up with First Word Publishing. We have exclusive rights to 3 copies of the First Word Dossier Report- BioSimilar Drugs in Europe: Threat or Opportunity to Innovation? ...

Generic Pharma 2.0 has teamed up with First Word Publishing. We have exclusive rights to 3 copies of the First Word Dossier Report- BioSimilar Drugs in Europe: Threat or Opportunity to Innovation?

We'd like to give these copies away. Please send us your name, email, phone number and company name & why the report is of interest to you and you'll be entered in a draw to one of the three full copies. (An approximate value of $3000!).

please email us at contest@genericlicensing.com!

*please note that applicants missing information will not be entered and all information is held in strict confidence by Generic Pharma 2.0 & First Word Publishing*

Statistics

Views

Total Views
3,124
Views on SlideShare
3,121
Embed Views
3

Actions

Likes
2
Downloads
180
Comments
0

3 Embeds 3

http://paper.li 1
http://www.linkedin.com 1
http://www.slashdocs.com 1

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Biosimilar drugs in europe   threat or opportunity to innovation -- toc, exec summary and sample pages Biosimilar drugs in europe threat or opportunity to innovation -- toc, exec summary and sample pages Document Transcript